Meet the Cell Shuttle

A factory-in-a-box for industrial scale cell therapy manufacturing.

Cellares’ Cell Shuttle

“Cellares’ revolutionary technology will be a game changer for the cell therapy industry!”

Carl June, MD

Professor in Immunotherapy

University of Pennsylvania

Cellares Advisory Board Member

It’s Time to Automate

The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks. Currently, there is no scalable manufacturing solution for cell therapies and existing processes are disjointed, cost prohibitive, failure prone and unable to meet market demand. 

$11.6B

Cell Therapy Manufacturing Market by 2030

Source: Roots Analysis

600+

Clinical Trials Underway

Source: Alliance for Regenerative Medicine

5%-10%

Of the Required Manufacturing Capacity Exists Today

Source: Kineticos Life Sciences

Taking on the Challenge

Cellares revolutionary technology is robust, cost-effective and will enable the parallel production of thousands of cell therapy doses per month. We’re saving lives by delivering safe and affordable access to novel cell therapies for patients in need.

  •  
    Automated
  •  
    Flexible
  •  
    Scalable
  •  
    Robust
  •  
    Cost-efficient
Select the icons above to learn more
True walk-away, end-to-end automation–from starting material to fill and finish.
Modular hardware supports the vast majority of cell therapy applications, including CAR-T, TCR, NK and HSC based worklflows. A purpose-built process design software puts the power to define manufacturing workflows at your fingertips.
The first manufacturing platform that scales from high-throughput preclinical work to commercial scale, empowering you to meet market demand for your drug.
Three-fold reduction in process failure rates through elimination of operator error and contamination during open transfer steps.
Up to 70% cost reduction compared to open and manual manufacturing processes.
Slide

Automated

True walk-away, end-to-end automation from loading the starting material to unloading a cell therapy product ready for administration.

Slide

Flexible

Modular hardware supports the vast majority of cell therapy applications, including CAR-T, TCR, NK and HSC based workflows. A purpose-built process design software puts the power to define manufacturing workflows at your fingertips.

Slide

Scalable

The first manufacturing platform that scales from high-throughput preclinical work to commercial scale, empowering you to meet market demand for your drug.

Slide

Robust

Three-fold reduction in process failure rates through elimination of operator error and contamination during open transfer steps.

Slide

Cost-efficient

Up to 70% cost reduction compared to open and manual manufacturing processes.

Join our Team

We are always looking for creative and passionate people to join our interdisciplinary team. 

 

Recent News

Fierce Pharma

Fierce Pharma

July 14th, 2021 – All aboard the Cell Shuttle: Cellares' cell therapy factory-in-a-box project attracts a 3rd partner in Poseida

Forbes

Forbes

July 28th, 2021 – Scalable Automation is Breaking the Bottleneck on Cell Therapy Manufacturing

Cellares Appoints John Tomtishen as Vice President of Operations

October 11, 2021 - Cellares Corporation, a life sciences technology company pioneering a revolutionary automated...

Fierce Pharma

July 14th, 2021 – All aboard the Cell Shuttle: Cellares’ cell therapy factory-in-a-box project attracts a 3rd partner in Poseida

Forbes

July 28th, 2021 - Scalable Automation is Breaking the Bottleneck on Cell Therapy Manufacturing